Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen's Lawsuit

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Zymo-Research-cfDNA

More Like This

PR Newswire associated0

Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH

PR Newswire associated0

Zymo Research Fights Back Against Qiagen's Lawsuit, Asserts Antitrust Violations and Attempts to Stifle Innovation

PR Newswire associated0

Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production

MAGic™ BioProcessing Secures Patent in USA and China

MyBio Are the New Exclusive Partner for QIAGEN in Ireland & Northern Ireland

PR Newswire associated0

Zymo Research Unveils PureRec DSN: The Most Selective Duplex-Specific Nuclease

GlobeNewswire associated0

BioProcess360 Partners Launches New Chromatography Company Through Transfer of IP, Assets and Personnel from LigaTrap Technologies

Court Revokes Two Advanced Cell Diagnostics Patents, Dismisses Infringement Claims Against Molecular Instruments and Orders Advanced Cell Diagnostics to Make Payment of £1.35 Million to Molecular Instruments